Malignant Respiratory System Neoplasm — Trials

Malignant Respiratory System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

11,125 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,648
Recruiting: 1,431
Ph III recruiting: 179
Growth YoY: +7.9%
Industry share: 37%
Top sponsor: AstraZeneca
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,490)

clinicaltrialsPublishedShowing 351–382 of 382 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03755739	Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors	recruiting	Phase 2 / Phase 3	200	Second Affiliated Hospital of Guangzhou Medical UniversityOTHER	1	Jun 25, 2024	clinicaltrials
NCT04143607	ASK120067 Versus Gefitinib as First-line Treatment for EGFRm Locally Advanced or Metastatic NSCLC	active not recruiting	Phase 3	337	Jiangsu Aosaikang Pharmaceutical Co., Ltd.INDUSTRY	1	Jun 14, 2024